This is a regulatory disclosure made by Zydus Lifesciences Limited to the BSE Limited and the National Stock Exchange of India Limited.
The disclosure, made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informs the exchanges that a meeting of the Company's Board of Directors is scheduled to be held on Tuesday, August 11, 2026.
The primary agenda for the meeting is to consider and approve the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The notice states the board will also consider "other agenda items," though these are not specified.
In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has declared a closed trading window for all its Directors and Designated Persons. The trading window was closed effective from the date of this notice, July 20, 2026, and will remain closed until Thursday, August 13, 2026. The trading window will reopen for trading on Friday, August 14, 2026.
The notice was signed and digitally submitted by Dhaval N. Soni, Company Secretary and Compliance Officer (Membership No. FCS7063), on July 20, 2026, at 12:05:42 IST.